Institute shares guiding principles for patient-centered care

The Louis W. Sullivan Institute for Healthcare Innovation has developed six key guiding principles of patient-centered care that expand on the Institute of Medicine's definition.

The institute is "dedicated to distributing health IT innovation to transform quality and efficiency of healthcare delivery worldwide."

The full document of guiding principles details the six main principles:

  1. Clearly Defined Roles
  2. Assessment of Patient and Clinical Care Team Competencies
  3. Patient-Centered Decision-Making
  4. Information Access and Exchange
  5. Information Accuracy
  6. Privacy and Security

“I am incredibly proud of the work our Patient Experience Council is doing to make strides in reshaping the way we look at healthcare from the patient’s perspective and experience of their own care,” said Kym Martin, MBA, CNC, CFT, co-chair of The Sullivan Institute’s Patient Experience Council. “As healthcare stakeholders explore strategies to deliver more patient-centric care, products and services, we see these guiding principles serving as the next step to ensuring that the patient engagement strategies being considered result in patient-experience centered outcomes.”

The Patient Experience Council represents a collective body of ePatients and eAdvocates committed to transforming healthcare from the patient perspective. They are charged with implementation of the patient engagement recommendations set forth in the 2013 WEDI Report, a roadmap for the future of healthcare information exchange launched December of 2013. 

Read the full document of guiding principles.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.